Generic Name and Formulations:
Diclofenac sodium 3%; gel; contains benzyl alcohol.
Indications for SOLARAZE:
Use lowest effective dose for shortest duration. Apply to lesions twice daily for 60–90 days.
Coronary artery bypass graft surgery.
Risk of serious cardiovascular events.
Increased risk of serious cardiovascular events (including MI, stroke). Avoid in recent MI, severe heart failure; if necessary, monitor. History of ulcer disease and/or GI bleeding. Severe renal or hepatic impairment. Avoid sun and UV light. Aspirin allergy. Asthma. Avoid eyes, and open skin wounds, infections, or exfoliative dermatitis. Elderly. Labor & delivery. Pregnancy (Cat.B); avoid in 3rd trimester. Nursing mothers: not recommended.
Increased risk of GI events with concomitant aspirin or oral NSAIDs. Concomitant other topical medications or products (eg, sunscreens, cosmetics): not studied.
Pruritus, rash, contact dermatitis, dry skin, exfoliation, local pain, paresthesia; cardiovascular thrombotic events, edema, photosensitivity.
Endocrinology Advisor Articles
- Diabetic Retinopathy Risk Not Increased With GLP-1 Receptor Agonist Use in T2D
- Concurrent Risk Factors and Microvascular Complications in Type 1 Diabetes
- Behavioral Weight Loss Interventions May Prevent Obesity
- Early Treatment Intensification and Faster Glycemic Control in T2D
- Executive Function Predicts T1D Management Into Emerging Adulthood
- Nutraceuticals May Benefit Patients Who Are Statin Intolerant
- Hypertension Treatments: ARBs
- Semaglutide vs Liraglutide for Weight Loss in Patients With Obesity
- Liraglutide May Lower Risk for Foot Amputation in Type 2 Diabetes
- Thyroid Hormone Levels, Body Composition, Insulin Resistance in Euthyroid Patients
- RET Inhibitor Gets Breakthrough Treatment Status for Medullary Thyroid Cancer
- Physical Activity as a Lifestyle Factor Influencing Early Menopause
- Situation Framing, Language Can Influence Decision-Making
- Gains in Insurance Coverage Seen for Lesbian, Gay, Bisexual Adults
- Oral Contraceptives Associated With Ventricular Repolarization Alterations